
Ligand Pharmaceuticals, Inc.
USD0.00
+0.00 (+19.23%)
CEO
Todd C. Davis
IPO Date
2022-11-01
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Exchange
OTC
Country
US
Open
$0.00
Prev. Close
$0.00
Day Low
$0.00
Day High
$0.00
52W Low
$0.00
52W High
$0.00
Market Cap
$0.00B
Volume
0.00M
| 24 Jul 2023 |
| Barclays |
| Overweight |
| Overweight |
| maintain |
| 1 Jun 2023 | HC Wainwright & Co. | Buy | Buy | maintain |
| 21 Feb 2023 | Benchmark | Buy | Buy | maintain |
| 22 Dec 2022 | Roth Capital | Buy | Buy | maintain |
| 20 Nov 2022 | Barclays | Overweight | Overweight | maintain |
| 24 Oct 2022 | Barclays | Overweight | Overweight | maintain |
| 1 Sept 2022 | Roth Capital | Buy | Buy | maintain |